CYBB and atherosclerosis: In this regard, butyrate was found to reduce endothelial NADPH oxidase 2 (Nox2) and reactive oxygen species by upregulating PPAR-δ/miR-181b pathway preventing endothelial dysfunction seen in atherosclerosis [45,57].